United Kingdom· GB-APID-528211000001102
Famotidine 20mg tablets
A famotidine product containing famotidine, registered in United Kingdom by A A H Pharmaceuticals Ltd. The same ATC class is registered in 15 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Famotidine is registered in 15 of 19 countries.
Countries holding a registration under ATC A02BA03 (famotidine), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 8 of them publish a price we can compare per daily dose
Famotidine · ATC A02BA03
15 / 19 countries
- Canada
- Czechiaprice
- Finlandprice
- Franceprice
- Germany
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of famotidine costs, country by country.
Normalised to the WHO defined daily dose (40 mg), the median price runs from $0.26 in Spain to $0.76 in Italy — a ×3.0 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Famotidine · price per daily dose (40 mg)
USD · FX 28 Sept 2026
- IT Italy$0.76
- FR France$0.59
- ES Spain$0.26
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Famotidine
- Manufacturer
- A A H Pharmaceuticals Ltd
- Country
- United Kingdom (GB)
- ATC code
- A02BA03
- ATC class
- Famotidine
- Defined daily dose
- 40 mg, O
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- October 2, 2026
Packs & prices · 2
- gtin5025903004691
- gtin5025903038344
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
778 interactions on record for famotidine.
Graded by severity as the source publishes them — 14 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Famotidine · interactions on record
778 records
- 14 severe
- 277 moderate
- 52 minor
- 434 info
Most severe, free to view
- AtazanavirJ05AE08severe
- RilpivirineJ05AG05severe
- DasatinibL01EA02severe
- NeratinibL01EH02severe
1 more interaction with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under A02BA03
Famotidine, as other registers publish it.
- United Statesacid controllerH E B
- United Statesacid controllerWalgreen Company
- United Statesacid controllerCVS Pharmacy
- United Statesacid controllerCVS Pharmacy
- United Statesacid controllerSafeway
- United StatesAcid ControllerH E B
- United StatesAcid ControllerH E B
- United StatesAcid ControllerWalgreen Company
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/6613a44c-c426-4bd0-8f65-033c7839dc35 GET /v1/drugs/6613a44c-c426-4bd0-8f65-033c7839dc35?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "528211000001102",
"desc": "Famotidine 20mg tablets (A A H Pharmaceuticals Ltd)",
"form": "Oral tablet",
"vpid": "42354011000001101",
"source": "dmd",
"vtm_id": "775919008",
"strength": "20 mg",
"substance": "Famotidine",
"ingredient": "Famotidine",
"supplier_code": "3144701000001104"
}See everything about famotidine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.